iCUP™ Drug Screening Device

The iCup™ Drug Screen is an all-inclusive, on-site urine drug screening device that simplifies the collection process and tests for up to 17 drugs.

iCup™ Drug Screening Device

The self-contained cup minimizes collector exposure to urine, while the device provides fast and reliable results within 5 minutes that can be photocopied for result recording. Adulteration test strips are also available.

  • Integrated test cup screens for 3-17 prescription and illicit drugs: AMP, BAR, BUP, BZO, COC,  MDMA, MTD, mAMP, OPI, OXY, PCP, PPX, TCA, and THC
  • Specimen validity combinations include: CRE, OX, PH, SG2
  • Self-contained collection cup and test help minimize exposure to urine
  • Fast results in 5 minutes 


1. Drugs of abuse: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC150 or COC300), Marijuana (THC), Methylenedioxymethamphetamine (MDMA), Methadone (MTD), Methamphetamine (mAMP1000 or mAMP500), Morphine (MOP300), Opiates (OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), and Tricyclic Antidepressants (TCA).

2. Specimen validity tests: Creatinine (CRE), Oxidants/PCC (OX), Potential Hydrogen (pH), Specific Gravity (SG)

Specific product configurations may be for professional in-vitro diagnostic. Consult with your sales representative for more details.

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.

Gas chromatography-mass spectrometry (GC-MS) is the preferred confirmatory method.

©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy and Cookie Policy. Notice of Privacy Practices: Santa Rosa, CA [pdf 681KB] | Gretna, LA [pdf 135KB] | Richmond, VA [pdf 135KB], HIPAA & Patient Info

Abbott - A Global Leader in Toxicology.

Alere Toxicology is now Abbott Toxicology

Please click "Accept Sale/Sharing and Targeted Advertising" to enable full site functionality.

At this time, we are experiencing problems with broken links on our site. As an interim solution, for full site functionality you must enable functional and advertising cookies. If you continue to opt-out of these cookies, some content on our site may not be viewable.

We use functional cookies to analyze your use of the site, improve performance and provide a better customer experience. We use advertising cookies to allow us, through certain data assigned and obtained from the user's device, to store or share with third parties information related to user's browsing activity in our website, in order to create an advertising profile and place relevant advertising in our website or those third parties websites. For more information about how Abbott uses cookies please see our Cookie Policy and Privacy Policy.

In order to accept functional and advertising cookies, please click "Enable Cookies" and then click "Accept Sale/Sharing and Targeted Advertising" to view the full site.

Learn more about cookies